Rwanda will deploy Marburg vaccine under trial as death toll rises to 12
Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever as the East African country tries to stop the spread of an outbreak that has killed 12 people
By IGNATIUS SSUUNA
Published - Oct 06, 2024, 07:08 AM ET
Last Updated - Dec 16, 2024, 06:36 PM EST
KIGALI, Rwanda (AP) — Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever, officials said Sunday, as the East African country tries to stop the spread of an outbreak that has killed 12 people.
Rwanda, which received 700 doses of a vaccine under trial from the U.S.-based Sabin Vaccine Institute on Saturday, will target health workers and emergency responders as well as individuals who have been in contact with confirmed cases, according to the Health Ministry.
Health Minister Sabin Nsanzimana told reporters Sunday that the Rwanda Biomedical Centre had reviewed the vaccine shipment.
There is no authorized vaccine or treatment for Marburg.
